Venture Capital Report

Similar documents
VentureSource Europe -- 3Q 2014

Venture Capital Report

Venture Capital Report

VentureSource U.S. -- 4Q 2013

Venture Capital Report

VentureSource China -- 3Q 2014

Venture Capital Report

Venture Capital Report

Venture Capital Report

VentureSource China -- 1Q 2014

Venture Capital Report

Venture Capital Report

Venture Capital Report

Venture Capital Report

AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS BACK 7% IN 1 ST QUARTER TO $6.84 BILLION

Silicon Valley Venture Capital Survey Second Quarter 2018

Venture Capital Industry Overview. Powered By:

VentureSource U.S. -- 3Q 2014

Venture Capital Report

Silicon Valley Venture Capital Survey Third Quarter 2017

Venture Capital Report

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010)

2013 venture capital trends summary

Digital Health Funding and M&A

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

The percentage of Series A rounds declined significantly, to 12% of all deals.

2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp

Israel Venture Capital Investments Report Q3 2017

2013 Global venture capital confidence survey results. How confident are investors?

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp

Global Clean Energy Review 2Q12 Analytics and Graphs VB/Research Ltd All rights reserved

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE

Central and Eastern Europe Statistics 2005

GLOBAL PRIVATE EQUITY Report Charts

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011)

CLEAN ENERGY PIPELINE 2Q15: GLOBAL CLEAN ENERGY REVIEW ANALYTICS AND GRAPHS

Canada Venture Capital Market Overview First Nine Months of 2015

Silicon Valley Venture Capital Survey Fourth Quarter 2018

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010

Trends in Healthcare Investments and Exits 2018

European Private Equity Buyout Review First Quarter Fabrizio Bensch REUTERS

European inv n estme m nt n s

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Overview of Venture Equity

German & Berlin Tech: performance on the international stage. 14 November 2018 in partnership with

EY survey of investment in innovative companies in France. First half of 2018

2011 Angel Group Year in Review

UNITED INTERNET. Business Applications Strategic Partnership with Warburg Pincus. November 8, Investor Presentation November 8, 2016

Venture Capital Search Highlights

European Trends in Healthcare Investments and Exits 2018

Average M&A Deal Size at Highest Level Since 2004

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Venture capital - An introduction into the nature of venture capital

Software was the Most Active and Highest Value Segment in 2015 with 1,288 Transactions Totaling $61.5 Billion in Reported Deal Value.

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Forum Science & Business FCRi - EY Foundation

OECD/ADBI 7th Round Table on Capital Market Reform in Asia October 2005 ADB Institute, Tokyo, Japan

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

Net Lease Investment Outlook

Moving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter.

Understanding Venture Capital

2014 Global venture capital confidence survey results

Angel Group Update: Q2 2013

Silicon Valley Venture Capital Survey Third Quarter 2017

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management

presents THE ANGEL CONNECTION

Florida Venture Factbook

5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% 16.00% 13.00% 10.00% 7.00% 4.

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

A report on investment gender diversity in the Nordics

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

Mary Macdonald November 2005

Private Equity-Backed Buyout Deals and Exits Down in Q Market Volatility and Tightened Credit Markets Lead to an Absence of Large-Cap Deals

Q Q Cleantech Investment Monitor VOL. 7 / ISSUE 1.

Private Equity Market Update. February 2013

Mara H. Rogers, Partner Norton Rose Fulbright

THE INSTITUTIONALIZATION OF THE PRE-IPO EQUITY MARKET

IVC-MEITAR HIGH-TECH EXITS 2015 REPORT 2015 exits peak at $9.02B 3 rd strongest year in 10 years

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

Software was the Most Active and Highest Value Segment in 3Q17 with 606 Transactions Totaling $29.4 Billion in Reported Deal Value

Information Technology: McGladrey Quarterly Private Equity Deal Flow Profile

EVCA Strategic Priorities

1H16 Summary of M&A and Investment Activity in the. Marketing, Media, and Technology Industries. 1,509 Transactions Totaling a Reported $74.

Co C m o pa p n a y n Pr P o r f o il i e l Nove v mb m e b r r

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA

24 May, Pan-European Private Equity and Venture Capital Activity

2017 Venture Capital Update. Bobby Franklin President & CEO, National Venture Capital Association (NVCA) January 2017

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Drivers of Innovation in the US High Tech Model

Transcription:

Europe 4Q 2014

The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive view of the trends currently affecting the venture capital market. Highlights for 4Q 2014 include: European venture capital fundraising experiences uptick from 3Q 2014, but suffers declines in both fund closings and euros raised for the 12 month period; Venture capital investment into European companies falls from 3Q 2014, but improves by a quarter year over year; Despite an overall fall in exit activity, the total amount raised through venture-backed Initial public offerings (IPOs) reached its highest point since 2Q 2000. 2

FUNDRAISING European Venture Capital Fundraising Experiences Uptick in 4Q 2014 18 European venture capital funds accumulated 927 million during 4Q 2014, an increase of 33% in euros raised and 20% in the number of funds with closings from 3Q 2014. Despite the uptick in fundraising from 3Q 2014, the number of funds with closings during 4Q 2014 fell by 51% compared with the same period last year, while euros raised fell by 49%. The largest fund of the quarter was Principia SGR s Fund III which raised 160 million, accounting for 17% of the total amount raised for 4Q 2014. Overall, the number of fund closings in 2014 was down by 4% to 76 from the year prior, while the total amount raised by venture funds fell by 18% from 2013 to 3.4 billion. European VC Fundraising (2011 2014) Based on multiple closings 40 35 30 2.50 2.00 25 20 1.50 15 1.00 10 5 0.50 0 4Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Amount Raised ( B) 2.17 0.98 1.18 0.76 1.19 0.76 1.03 0.50 1.81 0.69 1.03 0.70 0.93 Number of Funds 36 17 21 15 29 15 17 10 37 23 20 15 18 0.00 3

Largest European VC Funds Raised in 4Q 2014 FUNDRAISING Firm Name Fund Name Amount ( M) Closed in 4Q Location Offering Status Fund Type Fund Category Closing Type Principia SGR Principia Fund III 160.00 Milan, Italy Open Multi-stage venture capital Venture Capital First Infocomm Investments Pte. Ltd. Infocomm European Technology Fund 158.43 Singapore, Singapore Closed Early-stage venture capital Venture Capital Final Northzone Ventures AS Northzone VII 100.00 Oslo, Norway Closed Early-stage venture capital Venture Capital Final Forbion Capital Partners Forbion Capital Fund III 92.00 Naarden, Netherlands Open Multi-stage venture capital Venture Capital First Advent Venture Partners LLP Advent Life Sciences Fund II LP 70.24 London, United Kingdom Closed Multi-stage venture capital Venture Capital Final 4

Investment into European Venture-backed Companies Falls in 4Q 2014 European companies raised 1.8 billion for 332 deals during 4Q 2014, a fall of 24% in the amount raised from 3Q 2014 despite just five fewer deals being completed. In contrast with the year ago period, investment improved by 1% despite a 28% reduction in the number of completed deals. In 2014 as a whole, European venture-backed companies attracted 7.9 billion across 1460 deals, a decline of 11% in deals completed from 2013 but an improvement of 25% in euros invested. Equity Financings into Europe based, VC-backed Companies (2011 2014) 2.50 2.00 1.50 1.00 0.50 0.00 4Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Amount Raised ( B) 1.46 1.06 1.56 1.15 1.24 1.21 1.57 1.75 1.76 1.54 2.26 2.32 1.77 Number of Deals 374 347 375 326 373 371 420 384 461 387 404 337 332 500 450 400 350 300 250 200 150 100 50 0 5

Equity Financings into Europe-based, VC-backed Companies, by Round Class (2011 2014) Number of Deals 240 200 160 120 80 40 0 4Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Seed 45 38 38 53 61 35 34 52 67 32 24 19 23 First 168 161 192 155 187 197 207 197 207 210 203 176 171 Second 62 63 60 55 57 64 89 63 81 67 87 60 64 Later 73 70 55 46 43 53 65 51 81 56 73 65 55 Restart 3 0 0 0 0 0 0 0 0 0 0 0 0 6

Equity Financings into Europe-based, VC-backed Companies, by Round Class (Year over Year, 2004 2014 ) Number of Deals 900 800 700 600 500 400 300 200 100 0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Restart 14 9 10 12 5 3 2 6 0 0 0 Later 437 482 339 385 316 290 304 238 214 250 249 Second 289 283 242 267 274 251 268 261 235 297 278 First 519 541 643 845 712 598 669 664 695 808 760 Seed 66 55 93 100 99 93 97 134 190 188 98 7

Equity Financings into Europe-based, VC-backed Companies, by Round Class (2011 2014) Amount Raised ( M) 1,200 1,000 800 600 400 200 0 4Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Seed 23 17 23 15 26 20 14 19 27 16 17 11 14 First 433 298 537 289 449 403 418 526 349 441 563 510 403 Second 355 278 257 300 291 229 479 697 391 319 468 207 683 Later 604 448 673 531 449 543 639 458 937 642 1,039 877 647 Restart 15 0 0 0 0 0 0 0 0 0 0 0 0 8

Equity Financings into Europe-based, VC-backed Companies, Median Equity Deal Size ( M) (2011 2014) 2.50 2.00 1.50 1.00 0.50 0.00 4Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Median Equity Deal Size ( M) 1.41 1.50 1.90 1.20 1.22 1.50 1.52 1.00 1.40 1.58 2.00 2.00 2.30 9

Equity Financings into Europe-based, VC-backed Companies, by Industry Group (4Q 2014) Business and Financial received the largest allocation of investment during 4Q 2014 (32%), accumulating 557 million through 80 deals. The sector remained the most attractive sector despite investment dropping by 41% from 3Q 2014. Deal flow remained flat. Healthcare rose to second in terms of equity financing, taking a 30% share of all 4Q 2014 investment. The sector raised 535 million across 60 deals, an increase of 64% in capital raised and 25% in deals completed from the previous quarter. Consumer was pushed down to third, with companies in the sector gathering 18% of the total amount invested for the quarter. The sector received 327 million across 96 deals; a fall of 53% and 3% from 3Q 2014 in capital invested and deal flow respectively. 4Q'14 Industry Breakdown By Number of Deals 4Q 14 Industry Breakdown By Amount Raised 21% 24% Business and Financial Consumer Goods 1% 15% 32% Business and Financial Consumer Goods 2% Consumer Consumer 18% 2% Energy & Utilities Healthcare 30% 2% Energy & Utilities Healthcare 4% 29% Industrial Goods & Materials 2% 18% Industrial Goods & Materials (0.5%) Information Technology Information Technology 10

Equity Financings into Europe-based, VC-backed Companies, by Industry Group (2014) 2014 Industry Breakdown By Number of Deals 2014 Industry Breakdown By Amount Raised ($B) 38 260 406 Business and Financial Consumer Goods Consumer 1% 12% Business and Financial 31% Consumer Goods Consumer 220 44 432 56 Energy & Utilities Healthcare Industrial Goods & Materials 22% 3% 29% 2% Energy & Utilities Healthcare Industrial Goods & Materials Information Technology Information Technology 11

Top 5 Deals into European VC-backed Companies (4Q 2014) Co. Name Location Industry Group Industry Segment Industry Code Brief Description Close Date Round Type Raised ( M) Round Investors (* denotes lead) Adyen BV Netherlands Business and Financial Financial Institutions and Payment/ Transactional Processing Provider of an Internet payment system for international merchants. 16/12/2014 Second 199.60 Felicis Ventures, General Atlantic LLC*, Index Ventures, Temasek Holdings Pvt. Ltd. Verne Global Iceland Information Technology Electronics and Computer Hardware Data Storage Provider of renewable energy-powered data centers. 31/12/2014 Second 78.24 General Catalyst Partners, Novator Partners, Stefnir*, Wellcome Trust Powa Technologies Ltd. United Kingdom Business and Financial Financial Institutions and Payment/ Transactional Processing Provider of an integrated mobile payments and e-commerce platform. 7/11/2014 Second 63.88 Wellington Management Co. LLP* Cell Medica Ltd. United Kingdom Healthcare Biopharmaceuticals Biotechnology Therapeutics Provider of antigenspecific T-Cell immunotherapy treatments for the treatment of infectious disease and cancer. 25/11/2014 4th 63.87 Imperial Innovations*, Invesco Perpetual, Woodford Investment Management LLP Ascendis Pharma A/S Denmark Healthcare Biopharmaceuticals Drug Development Technologies Developer of long-acting prodrug therapies to address large markets with significant unmet medical needs. 24/11/2014 3rd 47.91 Janus Capital Group, OrbiMed Advisors LLC*, RA Capital Management LLC, Rock Springs Capital Management, Sectoral Asset Management Inc., Sofinnova Partners, Sofinnova Ventures Inc.*, Venrock, Vivo Capital* 12

Most Active Investors for Europe-based, VC-backed Companies by Deals Completed (4Q 2014) 18 17 16 14 12 10 8 6 8 7 6 6 4 2 0 High-Tech Gruenderfonds Management GmbH Truffle Capital SAS Bpifrance Investment Northzone Ventures AS Kima Ventures 13

Equity Financings into Europe-based, VC-backed Companies, by Country (4Q 2014) The United Kingdom was the most favoured destination for equity financing during 4Q 2014, receiving 524 million across 69 deals. The country took in 30% of all investment into European VC-backed companies for the quarter. Germany placed second, capturing 18% of European investment. Investment fell by 73% from the prior quarter to total 322 million. Deal flow remained relatively stable, however, with 66 completed. The Netherlands rose to third position raising 243 million, a 14% share of investment. France placed in fourth position with a 12% share, raising 218 million during 3Q 2014. Number of Deals in 4Q 2014 by Country (Top 4) Amount Raised in 4Q 2014 by Country (Top 4) 33% 21% 20% United Kingdom Germany France Spain Rest of Europe 12% 26% 30% United Kingdom Germany Netherlands France Rest of Europe 8% 18% 18% 14% 14

LIQUIDITY Europe Sees Overall Decrease in 4Q 2014 Venture Exit Activity 42 venture-backed M&As took place in Europe during 4Q 2014, down 9% from 3Q 2014 but one up on the figure for 4Q 2013. The largest M&A for 4Q 2014 was Belgium s Clear2Pay NV, an e-payment solutions provider, which was acquired by Fidelity National Information for 375 million. 55 venture-backed IPOs took place during 2014, tripling the number of listings seen across Europe in 2013. 201 M&As were completed during the course of 2014, a 21% increase on the 166 that took place during 2013. Exit Opportunities for European VC backed Companies (2011 2014) 4Q'14 3Q'14 2Q'14 1Q'14 4Q'13 3Q'13 2Q'13 1Q'13 4Q'12 3Q'12 2Q'12 1Q'12 4Q'11 0 10 20 30 40 50 60 70 4Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 IPOs 3 6 3 2 5 1 5 3 9 8 21 16 10 M&As 45 38 42 30 46 34 36 41 41 51 42 46 42 15

Top 3 M&As in Europe (4Q 2014) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Round Type Amount Paid ( M) Acquirer Clear2Pay NV Mechelen, Belgium Provider of e-payment solutions. Vertical Market Applications Software Software Information Technology 2/10/2014 Acquisition 375.00 FIdelity National Information SuperDerivatives Inc. London, United Kingdom Provider of cloudbased derivatives data and technology for financial and commodity markets worldwide. Financial Data/Information Financial Institutions and Business and Financial 8/10/2014 Acquisition 277.25 Intercontinental Exchange Telerik AD Sofia, Bulgaria Provider of an end-toend platform that combines user interface (UI) tools and cloud services. Software Development Tools Software Information Technology 2/12/2014 Acquisition 209.98 Progress Software Corp. 16

LIQUIDITY European VC-backed IPOs (2011-2014) 10 IPOs were completed during 4Q 2014, a decline of 38% from the previous quarter s total but an increase of one on those completed during 4Q 2013. IPOs raised 2.3 billion during 4Q 2014, more than six times the figure seen in 4Q 2013 and the highest sum since 2Q 2000 when 71 IPOs raised a total of 3.8 billion. The largest European VC-backed IPO of 4Q 2014 was Rocket Internet AG s October listing on the Frankfurt Stock Exchange. The company raised a total of 1.4 billion, accounting for 62% of the total amount raised through European venture-backed company IPOs for the quarter. European VC-backed IPO Activity (2011-2014) 2,500.00 25 2,000.00 20 1,500.00 15 1,000.00 10 500.00 5 0.00 4Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Raised ( M) through IPO 18.66 157.40 26.76 52.08 142.99 19.22 89.24 25.51 366.10 448.63 529.53 447.47 2,250 Number of IPOs 3 6 3 2 5 1 5 3 9 8 21 16 10 0 17

Top 3 IPOs in Europe (4Q 2014) LIQUIDITY Company Name Country Brief Description Industry Code Industry Segment Industry Group Close Date Raised through IPO ( M) Exchange/ Symbol Rocket Internet AG Germany Operator of an e- commerce focused Incubators/Business venture capital (VC) firm Development and a startup incubator. Business Support Business and Financial 2/10/2014 1,400.00 XETRA: RKET Zalando SE Germany Provider of an e- commerce platform specializing in the retail of brand name shoes. Clothing/Accessory Retailers Retailers Consumer 1/10/2014 526.24 XETRA: ZAL Forward Pharma A/S Denmark Developer of immunomodulatory drugs for the treatment of immune disorders. Biotechnology Therapeutics Biopharmaceuticals Healthcare 15/10/2014 174.67 NASDAQ: FWP 18

ABOUT US Dow Jones VentureSource helps venture capitalists, corporate development executives, investment bankers and service providers find deal and partnership opportunities, perform comprehensive due diligence, and examine trends in venture capital investment, fund-raising, and liquidity. It provides accurate, comprehensive data on venture-backed companies including their investors and executives in every region, industry, and stage of development throughout the world. The investment figures included in this release are based on aggregate findings of Dow Jones' proprietary research and are contained in VentureSource. This data was collected through surveys of professional firms, interviews with company executives, and from secondary sources. These venture capital statistics cover equity investments into early stage, innovative companies and do not include companies receiving funding solely from corporate, individual, and/or government investors. Figures contained throughout the report current at time of editorial but are subject to change without notice. No statement herein is to be construed as a recommendation to buy or sell securities or to provide investment advice. About Dow Jones Dow Jones & Company is a global provider of news and business information, delivering content to consumers and organizations via newspapers, Web sites, apps, video, newsletters, magazines, proprietary databases, conferences, and radio. Dow Jones has produced unrivalled quality content for over 120 years and today has one of the world s largest news-gathering operations with nearly 2,000 journalists in more than 80 bureaus, including The Wall Street Journal, America s largest newspaper by paid circulation. Other premier brands include Barron s, MarketWatch, and Dow Jones, its flagship news and analytics platform. Dow Jones publishes in 13 languages and distributes content in 28 languages, combining technology with news and data to support business decision making. The company pioneered the first successful paid online news site and its industry leading innovation enables it to serve customers wherever they may be, via the Web, mobile devices, Internet-connected televisions, and tablets. MEDIA CONTACT: Kate Dobbin 44 (0)20 7573 4016 Kate.Dobbin@dowjones.com 19